#obesity — Tuesday, April 21, 2026 (1 items)
| 0 | 💬 0 |
GZR18, a GLP-1 analog with once-weekly or bi-weekly dosing for body weight management: A randomized, placebo-controlled, phase 1b/2a trial.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-04-21 | #metabolism #clinical trial #obesity #pharmacology |